A man from rural India presented with redness and blurry vision in one eye. Examination was notable for panuveitis and a live worm in the posterior segment; the worm was removed in a pars plana vit ...

For patients with both chronic kidney disease and type 2 diabetes, whether combination therapy with finerenone and empagliflozin would improve outcomes over single-drug therapy is unclear. New ...

ESR1 mutations can emerge during first-line therapy and lead to endocrine resistance in advanced breast cancer. New research findings on switching to camizestrant after the detection of an ESR1 ...

Quick Take Video Summary from The New England Journal of Medicine — Ciprofloxacin vs. Aminoglycoside–Ciprofloxacin for Bubonic Plague ...

Audio Interview from the New England Journal of Medicine — Interview with Nancy Tomes on the century-long transition to a corporate business model in U.S. health care.

In patients with advanced breast cancer, switching to camizestrant with a CDK4/6 inhibitor after ESR1 -mutation detection (and before disease progression) led to significantly longer progression ...

Homozygous deficiency of alpha1-atitrypsin is known to predispose to pulmonary emphysema. Measurement of the trypsin inhibitory capacity (TIC) of serum specimens from 28 relatives of a homozygous p ...

THE constitutional character of atopic dermatitis is generally recognized.1 The frequent association of this dermatitis with hay fever, asthma and urticaria and the demonstration of specific antibo ...

“Corporatization” of health care, a process predicted decades ago, now refers to the general trend throughout the industry ...

Though infant mortality has continuously been targeted by health policy agendas, policies tend to place it in an individualistic and narrow frame, failing to consider and address its structural ...

Data on treatments for bubonic plague are limited. In this open-label, randomized, controlled trial in Madagascar, ciprofloxacin monotherapy was noninferior to a standard aminoglycoside ...

In this trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ...